| 引用本文: | 堵伟锋,贾微微,戴小华,程亚俊.自研双氯芬酸二乙胺乳胶剂体外释放一致性研究[J].中国现代应用药学,2026,43(18):154-159. |
| duweifeng,jiaweiwei,daixiaohua,chengyajun.Study on the consistency of in Vitro Release Between Self-developed Diclofenac Diethylamine Emulgel and Reference Preparation[J].Chin J Mod Appl Pharm(中国现代应用药学),2026,43(18):154-159. |
|
| 摘要: |
| 目的? 建立双氯芬酸二乙胺乳胶剂的体外释放试验评价方法,考察自研制剂与参比制剂体外释放行为的一致性。方法? 采用Franz扩散池系统(8 mL,有效面积3.141 cm2),以优选的接收介质、人工膜、上药量、转速和取样时间等条件对自研和参比制剂进行体外释放试验,以HPLC法测定药物释放量并计算释放速率。采用非参数Mann-Whitney U 检验法评价一致性。结果? 接收介质选择生理盐水,人工膜选择0.45μm再生纤维素膜(RC),上药量选择0.3g,转速选择 300 r·min-1,分别于0.167、0.5、1、2、3、4、6h取样,建立的体外释放方法经验证符合要求。3批自研制剂与3批参比制剂的体外释放释放速率比值的90%置信区间分别为96.76%~102.48%、101.31%~106.44%、101.44%~106.45%、96.14%~101.12%、100.65%~104.51%、100.37%~104.52%、93.88%~99.97%、98.97%~101.36%、98.65%~101.37%,均在75%~133.33%范围内。结论? 自研双氯芬酸二乙胺乳胶剂与参比制剂的体外释放行为一致,建立的方法为双氯芬酸二乙胺乳胶剂一致性评价提供了可靠依据。 |
| 关键词: 双氯芬酸二乙胺乳胶剂 体外释放 自研制剂 参比制剂 Franz扩散池 |
| DOI: |
| 分类号:R284.1;R917.101?????? |
| 基金项目:安徽省药监局科技创新项目 (AHYJ-KJ-202316) |
|
| Study on the consistency of in Vitro Release Between Self-developed Diclofenac Diethylamine Emulgel and Reference Preparation |
|
duweifeng1, jiaweiwei, daixiaohua, chengyajun2
|
|
1.Anhui Institute for Food and Drug Control;2.Front Pharmaceutical Plc
|
| Abstract: |
| ABSTRACT: OBJECTIVE To establish a method for evaluating the in vitro release of diclofenac diethylamine emulgel, and to investigate the consistency of the in vitro release behavior between the self-developed formulation and the reference formulation. METHODS Franz diffusion cell system (8 mL, effective area of 3.141cm2) was used to conduct the in vitro release test of self-developed and reference preparation under the conditions of optimized receiving medium, artificial membrane, dosage, rotating speed and sampling time, and the drug release amount was determined by HPLC method and the release rate was calculated. Agreement was assessed by the nonparametric Mann-Whitney U test. RESULTS Normal saline was selected as the receiving medium, 0.45μm regenerated cellulose membrane(RC)was selected as the artificial membrane, the dosage was 0.3g, the rotation speed was 300r·min-1, and the samples were taken at 0.167, 0.5, 1, 2, 3, 4 and 6 h, respectively.The established in vitro release method was verified to meet the requirements. The 90% confidence interval of the in vitro release rate ratio of the three batches of self-developed preparation to the three batches of reference preparation was 96.76% ~ 102.48%, 101.31% ~ 106.44%, 101.44% ~ 106.45%, 96.14% ~ 101.12%, 100.65% ~ 104.51%, 100.37% ~ 104.52%, 93.88% ~ 99.97%, 98.97% ~ 101.36%, 98.65% ~101.37%, all in the range of 75% ~ 133.33%. CONCLUSION The in vitro release behaviors of diclofenac diethylamine emulgel are consistent with that of the reference preparations, and the established method provides a reliable basis for the consistency evaluation of diclofenac diethylamine emulgel. |
| Key words: diclofenac diethylamine emulgel in vitro release self-developed preparation reference preparation Franz diffusion cell |